Schedule - Program Outline

Thursday, March 27, 2008

07:00a.m. – 08:00a.m.
Registration and Continental Breakfast
07:45a.m. – 07:55a.m.
Welcome and Introduction - Shahla Masood, M.D.
07:55a.m. – 08:05a.m.
Introduction of Keynote Speaker - James Crawford, M.D., Ph.D.
08:05a.m. – 08:30a.m.
Keynote Speaker: Beyond Genomics and Proteomics - Sudhir Srivastava, Ph.D.

Moderators - Edward Wilkinson, M.D. and Kenneth Rand, M.D.
08:30a.m. – 09:00a.m.
From Gene to Therapy - Kenneth Berns, M.D, Ph.D.
09:00a.m. – 09:30a.m.
The Story of Human Papilloma Virus (HPV) and Vaccine for Cervical Cancer - Mark E. Sherman, M.D.
09:30a.m. – 10:00a.m.
BREAK AND POSTER SESSION
10:00a.m. – 10:30a.m.
Human Immunodeficiency Virus (HIV) and Hepatitis C Virus, (HCV) Genotyping: The Impact and Outcome - Aaron Bossler, M.D., Ph.D.
10:30a.m. – 11:00a.m.
Molecular Diagnostics of Infectious Disease - James Versalovic, M.D., Ph.D.
11:00a.m. – 11:30a.m.
Direct Detection of Group B Streptococcus (GBS) in Pregnant Women - Jeanne A. Jordan, Ph.D.
11:30a.m. – 12:00a.m.
Antibiotic-Resistant Organisms an Emerging Pathogens - Gregory A. Storch, M.D.
12:00p.m. – 12:30p.m.
PANEL DISCUSSION
12:30p.m. – 01:30p.m.
LUNCH

Moderators - Raul Braylan, M.D. and Bruce Villas, M.D.
01:30p.m. – 02:00p.m.
The Role of Jak2 in Myeloproliferative Disorders - Peter Sayeski, Ph.D.
02:00p.m. – 02:30p.m.
Immunodeficiency – Related Lymphoproliferative Disorders: Correlation with Molecular – Genetic Findings - Amy Chadburn, M.D.
02:30p.m. – 03:00p.m.
Diagnostic Molecular Pathology of Lymphomas - Adam Bagg, M.D.
03:00p.m. – 03:30p.m.
PANEL DISUCSSION
05:00p.m. – 07:00p.m.
RECEPTION

Moderators - Azita Djalilvand, M.D. and Daniel J. Brat, M.D., Ph.D.
08:00a.m. – 08:30a.m.
Changing the Role of Pathologist: From Morphology to Molecular Targeted Therapy: History of Herceptin in Breast Cancer - Shahla Masood, M.D.
08:30a.m. – 09:00a.m.
Molecular Signature as Cancer Risk Predictor: In Breast and Colorectal Cancer - Henry Lynch, M.D.
09:00a.m. – 09:30a.m.
Forerunner Genes in the Development of in situ Bladder Neoplasia - Bogdan Czerniak, M.D.
09:30a.m. – 10:00a.m
Proteomics in Pathology Research and Diagnostics - Kojo S. J. Elenitoba-Johnson, M.D.
10:00a.m. – 10:30a.m.
BREAK AND POSTER SESSION
10:30a.m. – 11:00a.m.
Molecular Imaging - Martin Pomper, M.D., Ph.D.
11:00a.m. – 11:30a.m.
Genetic Alteration in Brain Tumors: GBM and Oligodendroglioma - Daniel J. Brat, M.D., Ph.D.
11:30a.m. – 11:45a.m.
PANEL DISCUSSION
11:45a.m. – 01:00p.m.
LUNCH

Moderators - Charles E. Hill, M.D., Ph.D. and Stephen Peiper, M.D.
01:00p.m. – 01:30p.m.
Overview of the Applications of Pharmacogenomics - Roland Valdes, Jr., Ph.D.
01:30p.m. – 02:00p.m.
Pharmacogenomics Contribution to Neuro-Psychiatric Treatment - Todd Skaar, Ph.D.
02:00p.m. – 02:30p.m.
Cytochrome P450 2C9 Genotype for Coumadin® resistance - Charles E. Hill, M.D., Ph.D.
02:30p.m. – 03:00p.m.
Overview of Pharmacogenetics in Medical Practice: Applications in Warfarin Therapy - Roland Valdes, Jr., Ph.D.
03:00p.m. – 03:30p.m.
BREAK AND POSTER SESSION

Moderators - James Crawford, M.D., Ph.D. and Bert Gold, Ph.D.
08:30a.m. – 09:00a.m.
Microarray-Based Comparative Genomic Hybridization (aCGH): Cytogenetic and Molecular Genetic Diagnostic Applications - David H. Ledbetter, Ph.D.
09:00a.m. – 09:30a.m.
Cystic Fibrosis - Wayne W. Grody, M.D., Ph.D.
09:30a.m. – 10:00a.m.
BREAK AND POSTER SESSION
10:00a.m. – 10:30a.m.
Mitochondrial Genetics and Disorders - Bert Gold, Ph.D.
10:30a.m. – 11:00a.m.
Ethics, HIPAA Regulations, and Reimbursement - David S. Wilkinson, M.D., Ph.D.
11:00a.m. – 11:30a.m.
Closing Remarks - Shahla Masood, M.D.
11:30a.m. – 12:00p.m.
PANEL DISCUSSION
12:00 ADJOURN